DECIPHERA PHARMACEUTICALS IN's ticker is DCPH and the CUSIP is 24344T101. A total of 146 filers reported holding DECIPHERA PHARMACEUTICALS IN in Q1 2023. The put-call ratio across all filers is 0.80 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $606,642 | -5.2% | 47,692 | +4.9% | 0.00% | 0.0% |
Q2 2023 | $640,020 | -24.1% | 45,456 | -16.7% | 0.00% | -33.3% |
Q1 2023 | $843,045 | +32.2% | 54,566 | +40.3% | 0.00% | +50.0% |
Q4 2022 | $637,604 | -16.5% | 38,902 | -5.8% | 0.00% | 0.0% |
Q3 2022 | $764,000 | +37.2% | 41,289 | -2.6% | 0.00% | +100.0% |
Q2 2022 | $557,000 | -47.1% | 42,373 | -62.7% | 0.00% | -50.0% |
Q1 2022 | $1,053,000 | +107.7% | 113,600 | +118.9% | 0.00% | +100.0% |
Q4 2021 | $507,000 | -71.3% | 51,900 | 0.0% | 0.00% | -75.0% |
Q3 2021 | $1,764,000 | -7.2% | 51,900 | 0.0% | 0.00% | 0.0% |
Q2 2021 | $1,900,000 | -18.3% | 51,900 | 0.0% | 0.00% | -20.0% |
Q1 2021 | $2,327,000 | -23.7% | 51,900 | -2.8% | 0.01% | -28.6% |
Q4 2020 | $3,048,000 | -10.6% | 53,400 | -19.7% | 0.01% | -22.2% |
Q3 2020 | $3,411,000 | -7.0% | 66,500 | +8.3% | 0.01% | -10.0% |
Q2 2020 | $3,667,000 | +192.0% | 61,400 | +101.3% | 0.01% | +150.0% |
Q1 2020 | $1,256,000 | -8.7% | 30,500 | +38.0% | 0.00% | +33.3% |
Q4 2019 | $1,375,000 | +83.3% | 22,100 | 0.0% | 0.00% | +50.0% |
Q3 2019 | $750,000 | +176.8% | 22,100 | +84.2% | 0.00% | +100.0% |
Q2 2019 | $271,000 | -0.4% | 12,000 | +2.6% | 0.00% | 0.0% |
Q1 2019 | $272,000 | -11.1% | 11,700 | +48.1% | 0.00% | 0.0% |
Q3 2018 | $306,000 | – | 7,900 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
New Leaf Venture Partners, L.L.C. | 1,209,571 | $69,030,000 | 15.95% |
SV Health Investors, LLC | 449,951 | $25,679,000 | 12.37% |
Sunesis Advisors, LLC | 96,299 | $5,496,000 | 4.45% |
Redmile Group, LLC | 4,437,968 | $253,275,000 | 3.07% |
Consonance Capital Management LP | 484,671 | $27,660,000 | 2.58% |
SECTORAL ASSET MANAGEMENT INC | 488,842 | $27,898,000 | 1.97% |
Opaleye Management Inc. | 222,000 | $12,670,000 | 1.66% |
Eversept Partners, LP | 246,240 | $14,052,917 | 1.65% |
SILVERARC CAPITAL MANAGEMENT, LLC | 38,620 | $2,204,000 | 1.28% |
Avoro Capital Advisors LLC | 1,300,000 | $74,191,000 | 1.28% |